世界のパシレオチド薬市場 2019年

【英語タイトル】Global Pasireotide Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料(QYR20FB01596)・商品コード:QYR20FB01596
・発行会社(調査会社):QYResearch
・発行日:2019年11月(※2024年版があります。お問い合わせください)
・ページ数:101
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、パシレオチド薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、0.3mg/ml、0.6mg/ml、0.9mg/mlに、用途別には、病院、薬局にセグメント区分し、パシレオチド薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・パシレオチド薬の世界市場概要
・パシレオチド薬の製造コスト構成分析
・パシレオチド薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・パシレオチド薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・パシレオチド薬のセグメント分析(種類別)
(0.3mg/ml、0.6mg/ml、0.9mg/ml)
・パシレオチド薬のセグメント分析(用途別)
(病院、薬局)
・パシレオチド薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Novartis)
・パシレオチド薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

Pasireotide is an orphan drug approved in the United States and Europe for the treatment of Cushing’s disease in patients who fail or are ineligible for surgical therapy.
The global Pasireotide Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pasireotide Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pasireotide Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pasireotide Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pasireotide Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
0.3mg/ml
0.6mg/ml
0.9mg/ml

Segment by Application
Hospital
Pharmacy

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Pasireotide Drugs
1.1 Definition of Pasireotide Drugs
1.2 Pasireotide Drugs Segment by Type
1.2.1 Global Pasireotide Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 0.3mg/ml
1.2.3 0.6mg/ml
1.2.4 0.9mg/ml
1.3 Pasireotide Drugs Segment by Applications
1.3.1 Global Pasireotide Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Pasireotide Drugs Overall Market
1.4.1 Global Pasireotide Drugs Revenue (2014-2025)
1.4.2 Global Pasireotide Drugs Production (2014-2025)
1.4.3 North America Pasireotide Drugs Status and Prospect (2014-2025)
1.4.4 Europe Pasireotide Drugs Status and Prospect (2014-2025)
1.4.5 China Pasireotide Drugs Status and Prospect (2014-2025)
1.4.6 Japan Pasireotide Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Pasireotide Drugs Status and Prospect (2014-2025)
1.4.8 India Pasireotide Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Pasireotide Drugs
2.3 Manufacturing Process Analysis of Pasireotide Drugs
2.4 Industry Chain Structure of Pasireotide Drugs

3 Development and Manufacturing Plants Analysis of Pasireotide Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Pasireotide Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Pasireotide Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Pasireotide Drugs Production and Capacity Analysis
4.2 Pasireotide Drugs Revenue Analysis
4.3 Pasireotide Drugs Price Analysis
4.4 Market Concentration Degree

5 Pasireotide Drugs Regional Market Analysis
5.1 Pasireotide Drugs Production by Regions
5.1.1 Global Pasireotide Drugs Production by Regions
5.1.2 Global Pasireotide Drugs Revenue by Regions
5.2 Pasireotide Drugs Consumption by Regions
5.3 North America Pasireotide Drugs Market Analysis
5.3.1 North America Pasireotide Drugs Production
5.3.2 North America Pasireotide Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Pasireotide Drugs Import and Export
5.4 Europe Pasireotide Drugs Market Analysis
5.4.1 Europe Pasireotide Drugs Production
5.4.2 Europe Pasireotide Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Pasireotide Drugs Import and Export
5.5 China Pasireotide Drugs Market Analysis
5.5.1 China Pasireotide Drugs Production
5.5.2 China Pasireotide Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Pasireotide Drugs Import and Export
5.6 Japan Pasireotide Drugs Market Analysis
5.6.1 Japan Pasireotide Drugs Production
5.6.2 Japan Pasireotide Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Pasireotide Drugs Import and Export
5.7 Southeast Asia Pasireotide Drugs Market Analysis
5.7.1 Southeast Asia Pasireotide Drugs Production
5.7.2 Southeast Asia Pasireotide Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Pasireotide Drugs Import and Export
5.8 India Pasireotide Drugs Market Analysis
5.8.1 India Pasireotide Drugs Production
5.8.2 India Pasireotide Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Pasireotide Drugs Import and Export

6 Pasireotide Drugs Segment Market Analysis (by Type)
6.1 Global Pasireotide Drugs Production by Type
6.2 Global Pasireotide Drugs Revenue by Type
6.3 Pasireotide Drugs Price by Type

7 Pasireotide Drugs Segment Market Analysis (by Application)
7.1 Global Pasireotide Drugs Consumption by Application
7.2 Global Pasireotide Drugs Consumption Market Share by Application (2014-2019)

8 Pasireotide Drugs Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Pasireotide Drugs Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Pasireotide Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served

9 Development Trend of Analysis of Pasireotide Drugs Market
9.1 Global Pasireotide Drugs Market Trend Analysis
9.1.1 Global Pasireotide Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Pasireotide Drugs Regional Market Trend
9.2.1 North America Pasireotide Drugs Forecast 2019-2025
9.2.2 Europe Pasireotide Drugs Forecast 2019-2025
9.2.3 China Pasireotide Drugs Forecast 2019-2025
9.2.4 Japan Pasireotide Drugs Forecast 2019-2025
9.2.5 Southeast Asia Pasireotide Drugs Forecast 2019-2025
9.2.6 India Pasireotide Drugs Forecast 2019-2025
9.3 Pasireotide Drugs Market Trend (Product Type)
9.4 Pasireotide Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Pasireotide Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer



【掲載企業】

Novartis

★調査レポート[世界のパシレオチド薬市場 2019年] (コード:QYR20FB01596)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のパシレオチド薬市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆